Stocks › BSAC
Banco Santander Chile BSAC
US equityMarket cap rank #1147
$30.04 −$0.22 (-0.73%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $30.04 0.00%
Open$30.09
Prev close$30.26
Day range$29.89 – $30.52
Volume455.4K
Market cap$14.15B
P/E (TTM)12.9
Dividend yield4.61%
Fundamentals
Latest reported quarter: Q3, ended Sep 2026 · reported in CLP
RevenueCLP 700.58B-0.5% YoY
Net profitCLP 244.02B-2.7% YoY
Diluted EPSCLP 503.24-4.2% YoY
Free cash flowCLP 1.09T+1,190.7% YoY
Operating cash flowCLP 1.11T
Revenue, last 8 quarters
Net profit, last 8 quarters
Diluted EPS by quarter
Free cash flow by quarter
Annual revenue
Profitability & balance sheet
Net margin37.9%
Return on equity23.4%
Return on assets1.5%
Liabilities / assets93.5%
Cash & investmentsCLP 3.92T
Total debtCLP 10.75T
Net cash (debt)-CLP 6.83T
Where the revenue comes from
Quarter 2026/Q3
By business line
This company reports in its own local currency, not U.S. dollars. Every figure below is labeled with its real currency, not automatically converted.
Income statement
| Line item | 2026 Q3 (CLP) |
2026 Q2 (CLP) |
2026 Q1 (CLP) |
2025 ANNUAL (CLP) |
2025 Q4 (CLP) |
|---|---|---|---|---|---|
| Total Operating Revenue | CLP 700.58B | CLP 831.72B | CLP 732.20B | CLP 2.85T | CLP 680.11B |
| Net Interest Income | CLP 447.10B | CLP 447.70B | CLP 457.51B | CLP 1.99T | CLP 693.01B |
| -Interest Income | CLP 860.22B | CLP 842.17B | CLP 832.30B | CLP 3.80T | CLP 1.25T |
| -Interest Expense | CLP 413.12B | CLP 394.46B | CLP 374.79B | CLP 1.81T | CLP 553.45B |
| Non-Interest Income | CLP 253.47B | CLP 384.02B | CLP 274.69B | CLP 864.47B | -CLP 12.91B |
| -Fees and Commissions | CLP 130.45B | CLP 141.39B | CLP 154.93B | CLP 594.80B | CLP 153.66B |
| -Trading Gain Loss | CLP 98.78B | CLP 42.62B | CLP 131.36B | – | – |
| -Foreign Exchange Trading Gains | -CLP 39.50B | CLP 21.87B | -CLP 55.14B | -CLP 10.83B | -CLP 147.73B |
| -Other Non-Interest Income | CLP 1.71B | -CLP 312.60B | CLP 5.28B | CLP 6.42B | CLP 4.28B |
| -Gain Loss on Sale of Assets | CLP 62.02B | CLP 490.72B | CLP 38.25B | CLP 273.85B | CLP 53.10B |
| Credit Losses Provision | -CLP 155.93B | -CLP 125.78B | -CLP 158.78B | -CLP 575.31B | -CLP 145.02B |
| Non-Interest Expense | CLP 253.23B | CLP 250.50B | CLP 228.86B | CLP 1.00T | CLP 222.79B |
| Selling and Admin Expenses | CLP 207.55B | CLP 197.26B | CLP 183.95B | CLP 772.53B | CLP 163.23B |
| -General & Admin Expense | CLP 207.55B | CLP 190.39B | CLP 179.99B | CLP 751.43B | CLP 142.12B |
| Depreciation & Amortization & Depletion | CLP 31.69B | CLP 32.14B | CLP 34.52B | CLP 135.16B | CLP 34.01B |
| -Depreciation & Amortization | CLP 31.69B | CLP 32.14B | CLP 34.52B | CLP 135.16B | CLP 34.01B |
| Other Non-Interest Expenses | CLP 13.99B | CLP 18.81B | CLP 8.85B | CLP 84.46B | CLP 16.67B |
| Other Income (Expense) | -CLP 691.00M | -CLP 4.48B | -CLP 8.17B | -CLP 29.40B | -CLP 32.54B |
| Income from Associates & Other Participating Interests | CLP 1.53B | CLP 1.95B | CLP 1.23B | CLP 9.29B | CLP 2.43B |
| Special Income (Charges) | -CLP 2.22B | -CLP 6.42B | -CLP 9.40B | -CLP 38.68B | -CLP 34.97B |
| -Less:Other Special Charges | CLP 2.22B | CLP 98.00M | CLP 80.00M | CLP 773.00M | -CLP 22.00M |
| -Less:Write Off | CLP 0.00 | – | CLP 0.00 | CLP 3.75B | CLP 823.00M |
| Pretax Profit | CLP 290.73B | CLP 450.97B | CLP 336.39B | CLP 1.25T | CLP 279.77B |
| Tax | CLP 46.71B | CLP 59.14B | CLP 55.91B | CLP 207.36B | CLP 51.13B |
| Net Profit | CLP 244.02B | CLP 391.82B | CLP 280.48B | CLP 1.04T | CLP 228.63B |
| Profit from Continuing Operations | CLP 244.02B | CLP 391.82B | CLP 280.48B | CLP 1.04T | CLP 228.63B |
| Minority Interests | CLP 6.93B | CLP 9.25B | CLP 7.29B | CLP 16.40B | CLP 4.85B |
| Net Income to Parent Company | CLP 237.09B | CLP 382.57B | CLP 273.19B | CLP 1.02T | CLP 223.78B |
| Net Income to Common Stockholders | CLP 237.09B | CLP 382.57B | CLP 273.19B | CLP 1.02T | CLP 223.78B |
| Basic EPS | CLP 503.24 | CLP 812.00 | CLP 560.00 | CLP 2,168.40 | CLP 560.00 |
| Diluted EPS | CLP 503.24 | CLP 812.00 | CLP 560.00 | CLP 2,168.40 | CLP 560.00 |
| Dividend Per Share | CLP 0.00 | CLP 1,346.99 | CLP 0.00 | CLP 1,254.21 | CLP 0.00 |
| -Total Premiums Earned | – | CLP 10.00M | CLP 5.00M | CLP 218.00M | CLP 136.00M |
| Occupancy and Equipment | – | CLP 816.00M | CLP 855.00M | – | – |
| Professional Expense and Contract Services Expense | – | CLP 1.48B | CLP 692.00M | CLP 8.88B | CLP 2.16B |
| -Selling & Marketing Expense | – | CLP 6.86B | CLP 3.96B | CLP 21.10B | CLP 5.07B |
| -Less:Restructuring and Mergern & Acquisition | – | CLP 6.33B | CLP 9.19B | CLP 34.16B | CLP 14.96B |
| -Less:Impairment of Capital Assets | – | CLP 0.00 | CLP 134.00M | – | – |
| Net Income from Discontinuous Operations | – | CLP 0.00 | – | CLP 0.00 | – |
Balance sheet
| Line item | 2026 Q3 (CLP) |
2026 Q2 (CLP) |
2026 Q1 (CLP) |
2025 ANNUAL (CLP) |
2025 Q4 (CLP) |
|---|---|---|---|---|---|
| Total Assets | CLP 78.14T | CLP 70.32T | CLP 69.90T | CLP 68.15T | CLP 68.15T |
| Cash, Cash Equivalents & Federal Funds Sold | CLP 5.11T | CLP 9.23T | CLP 7.73T | CLP 8.61T | CLP 8.61T |
| -Cash and Cash Equivalents | CLP 3.92T | CLP 5.73T | CLP 6.27T | CLP 5.24T | CLP 5.24T |
| -Money Market Investments | CLP 1.18T | CLP 2.13T | CLP 1.06T | CLP 2.22T | CLP 2.22T |
| Securities Investment | CLP 11.73T | CLP 8.20T | CLP 9.25T | CLP 6.92T | CLP 6.92T |
| -Available for Sale Securities | CLP 5.74T | CLP 5.68T | CLP 5.58T | CLP 5.53T | CLP 5.53T |
| -Short Term Investments | CLP 5.99T | CLP 2.52T | CLP 3.66T | CLP 1.40T | CLP 1.40T |
| Long Term Equity Investment | CLP 71.62B | CLP 68.34B | CLP 68.31B | CLP 67.04B | CLP 67.04B |
| Derivative Assets | CLP 15.97T | CLP 11.00T | CLP 11.39T | CLP 11.26T | CLP 11.26T |
| Net Loan | CLP 39.79T | CLP 39.56T | CLP 39.88T | CLP 39.06T | CLP 39.06T |
| -Gross Loan | CLP 41.18T | CLP 40.92T | CLP 41.27T | CLP 40.25T | CLP 40.25T |
| -Allowance for Loans and Lease Losses | CLP 1.40T | CLP 1.36T | CLP 1.39T | CLP 1.19T | CLP 1.19T |
| Receivables | CLP 948.88B | CLP 1.20T | CLP 502.43B | CLP 1.14T | CLP 1.14T |
| -Other Receivables | CLP 948.88B | CLP 1.01T | CLP 393.92B | CLP 1.04T | CLP 1.04T |
| Net PPE | CLP 284.58B | CLP 278.87B | CLP 277.62B | CLP 272.44B | CLP 272.44B |
| -Gross PPE | CLP 284.58B | CLP 1.00T | CLP 992.08B | CLP 981.36B | CLP 981.36B |
| Goodwill and Other Intangible Assets | CLP 89.49B | CLP 84.45B | CLP 83.12B | CLP 91.48B | CLP 91.48B |
| -Other Intangible Assets | CLP 89.49B | CLP 84.45B | CLP 83.12B | CLP 91.48B | CLP 91.48B |
| Deferred Assets | CLP 525.61B | CLP 493.29B | CLP 457.45B | CLP 387.70B | CLP 387.70B |
| Assets Held for Sale | CLP 78.12B | CLP 80.01B | CLP 82.31B | CLP 114.00B | CLP 114.00B |
| Other Assets | CLP 3.55T | CLP 97.98B | CLP 132.39B | CLP 197.70B | CLP 197.70B |
| Total Liabilities | CLP 73.03T | CLP 65.19T | CLP 65.00T | CLP 62.41T | CLP 62.41T |
| Total Deposits | CLP 33.31T | CLP 30.70T | CLP 29.52T | CLP 29.10T | CLP 29.10T |
| Federal Funds Purchased and Securities Sold Under Agreement to Repurchase | CLP 3.91T | CLP 3.23T | CLP 2.78T | CLP 2.76T | CLP 2.76T |
| Derivative Product Liabilities | CLP 15.63T | CLP 12.46T | CLP 13.32T | CLP 13.09T | CLP 13.09T |
| Payables | CLP 61.92B | CLP 626.81B | CLP 893.64B | CLP 859.55B | CLP 859.55B |
| -Total Tax Payable | CLP 61.92B | CLP 76.74B | CLP 83.86B | CLP 111.72B | CLP 111.72B |
| Long Term Debt and Capital Lease Obligation | CLP 10.75T | CLP 13.28T | CLP 13.69T | CLP 13.12T | CLP 13.12T |
| -Long Term Debt | CLP 10.69T | CLP 13.25T | CLP 13.65T | CLP 13.08T | CLP 13.08T |
| -Long Term Capital Lease Obligation | CLP 60.79B | CLP 37.79B | CLP 39.19B | CLP 34.02B | CLP 34.02B |
| Non-Current Liabilities | CLP 1.02T | CLP 759.51B | CLP 1.15T | CLP 838.45B | CLP 838.45B |
| Non-Current Deferred Liabilities | CLP 4.60B | CLP 12.53B | CLP 7.94B | CLP 8.26B | CLP 8.26B |
| Other Liabilities | CLP 8.34T | CLP 4.09T | CLP 3.63T | CLP 2.64T | CLP 2.64T |
| Total Equity | CLP 5.11T | CLP 5.14T | CLP 4.89T | CLP 5.74T | CLP 5.74T |
| Stockholders' Equity | CLP 4.94T | CLP 4.97T | CLP 4.74T | CLP 5.62T | CLP 5.62T |
| Capital Stock | CLP 891.30B | CLP 891.30B | CLP 891.30B | CLP 891.30B | CLP 891.30B |
| -Common Stock | CLP 891.30B | CLP 891.30B | CLP 891.30B | CLP 891.30B | CLP 891.30B |
| Retained Earnings | CLP 931.86B | CLP 694.77B | CLP 1.35T | CLP 661.60B | CLP 661.60B |
| Gains/Losses Not Affecting Retained Earnings | CLP 3.12T | CLP 3.39T | CLP 2.50T | CLP 3.43T | CLP 3.43T |
| Minority Interests | CLP 171.64B | CLP 164.11B | CLP 154.49B | CLP 119.94B | CLP 119.94B |
| -Restricted Cash and Investments | – | CLP 1.36T | CLP 400.79B | CLP 1.15T | CLP 1.15T |
| -Accounts Receivable | – | CLP 185.15B | CLP 108.51B | CLP 99.44B | CLP 99.44B |
| -Accumulated Depreciation | – | -CLP 721.87B | -CLP 714.45B | -CLP 708.92B | -CLP 708.92B |
| Prepaid Assets | – | CLP 47.43B | CLP 50.40B | CLP 24.40B | CLP 24.40B |
| Defined Pension Benefit | – | CLP 847.00M | CLP 738.00M | CLP 693.00M | CLP 693.00M |
| Short-Term Debt and Capital Lease Obligation | – | CLP 10.98B | CLP 10.78B | CLP 6.63B | CLP 6.63B |
| -Current Capital Lease Obligation | – | CLP 10.98B | CLP 10.78B | CLP 6.63B | CLP 6.63B |
| -Accounts Payable | – | CLP 487.42B | CLP 413.99B | CLP 647.79B | CLP 647.79B |
| -Other Payable | – | CLP 62.66B | CLP 395.78B | CLP 100.04B | CLP 100.04B |
| Other Equity Interests | – | – | – | CLP 629.47B | CLP 629.47B |
Cash flow
| Line item | 2026 Q2 (CLP) |
2026 Q1 (CLP) |
2025 ANNUAL (CLP) |
2025 Q4 (CLP) |
2025 Q3 (CLP) |
|---|---|---|---|---|---|
| Operating Cash Flow | CLP 1.11T | CLP 97.30B | CLP 55.41B | -CLP 365.64B | CLP 321.27B |
| Net cash flow from continuing operations | CLP 1.11T | CLP 97.30B | CLP 55.41B | -CLP 365.64B | CLP 321.27B |
| Net Income from Continuing Operations | CLP 450.97B | CLP 336.39B | CLP 1.04T | CLP 72.40B | CLP 304.48B |
| Gain/Loss from Continuing Operations | -CLP 1.65B | -CLP 2.10B | -CLP 28.50B | -CLP 18.93B | -CLP 4.97B |
| Depreciation & Depletion & Amortization | CLP 32.14B | CLP 34.52B | CLP 135.16B | CLP 34.01B | CLP 33.12B |
| Other Non-Cash Items | -CLP 880.07B | -CLP 372.24B | -CLP 2.80T | -CLP 1.01T | -CLP 546.47B |
| Change in Working Capital | CLP 626.54B | -CLP 172.37B | -CLP 40.87B | CLP 163.76B | CLP 58.52B |
| -Change in Loans | CLP 114.54B | -CLP 563.99B | CLP 2.87T | -CLP 239.44B | CLP 1.14T |
| -Change in Other Current Assets | CLP 1.38B | CLP 2.25B | -CLP 20.38B | -CLP 19.50B | -CLP 1.14B |
| -Change in Other Working Capital | CLP 566.53B | CLP 333.46B | -CLP 2.89T | CLP 422.71B | -CLP 1.08T |
| Net cash flow from investing | -CLP 16.95B | -CLP 4.36B | -CLP 104.95B | -CLP 48.12B | -CLP 14.56B |
| Net Cash Flow from Continuing Investing Activities | -CLP 16.95B | -CLP 4.36B | -CLP 104.95B | -CLP 48.12B | -CLP 14.56B |
| Net PPE Purchase and Sale | -CLP 4.76B | -CLP 1.38B | -CLP 52.08B | -CLP 21.96B | -CLP 3.34B |
| Net Intangibles Purchase and Sale | -CLP 12.20B | -CLP 2.98B | -CLP 52.87B | -CLP 26.16B | -CLP 11.22B |
| Financing Cash Flow | -CLP 1.08T | -CLP 85.91B | -CLP 621.10B | CLP 448.42B | -CLP 107.45B |
| Net Cash Flow from Continuing Financing Activities | -CLP 1.08T | -CLP 85.91B | -CLP 621.10B | CLP 448.42B | -CLP 107.45B |
| Net Issuance Payments of Debt | CLP 353.66B | CLP 621.84B | -CLP 20.76B | -CLP 1.41T | CLP 233.66B |
| Cash Dividends Paid | -CLP 631.93B | CLP 0.00 | -CLP 600.34B | CLP 0.00 | CLP 0.00 |
| Ending Cash Balance | CLP 2.02T | CLP 1.99T | CLP 2.09T | CLP 2.09T | CLP 2.07T |
| Net Change in Cash | CLP 13.46B | CLP 7.03B | -CLP 670.64B | CLP 34.67B | CLP 199.26B |
| Beginning Cash Balance | CLP 1.99T | CLP 1.98T | CLP 2.77T | CLP 2.07T | CLP 1.86T |
| Effect of Exchange Rate Changes | CLP 12.29B | CLP 10.39B | -CLP 7.31B | -CLP 10.09B | CLP 4.81B |
| Free Cash Flow | CLP 1.09T | CLP 91.77B | -CLP 82.12B | -CLP 437.83B | CLP 301.46B |
| -Change in Payables and Accrued Expense | – | CLP 55.91B | – | – | – |
| Net Investment Purchase and Sale | – | CLP 0.00 | – | – | – |
| Deferred Tax | – | – | -CLP 38.80B | -CLP 195.03B | CLP 53.61B |
| Net Business Purchase and Sale | – | – | – | – | CLP 0.00 |
No comments yet — be the first to weigh in on BSAC.
Sign in to join the discussion.